LHX:NYSEL3Harris Technologies, Inc. Analysis
Data as of 2026-08-28 - not real-time
$262.82
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At $262.82, L3Harris Technologies, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 6.8% over the past 30 days. Momentum indicators put RSI at 34.1 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near $258.54 and resistance around $294.14.
Valuation screens as undervalued: a P/E of 26.5 sits in line with the sector average of 29.4. Sell-side targets cluster 29.2% above the current quote. Revenue is growing at 190.0% on a 10.4% profit margin. The 1.91% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 38.9%, a beta of 0.31 and a maximum drawdown of 30.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.
Valuation screens as undervalued: a P/E of 26.5 sits in line with the sector average of 29.4. Sell-side targets cluster 29.2% above the current quote. Revenue is growing at 190.0% on a 10.4% profit margin. The 1.91% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 38.9%, a beta of 0.31 and a maximum drawdown of 30.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.
Top Market Events
L3Harris Technologies Inc. LHX stock traded lower on Thursday after the company reported second-quarter financial...L3Harris Technologies, Inc. NYSE:LHX fell 4.6% on August 17 after abruptly replacing Chairman and CEO Christopher...L3Harris extended its five-quarter earnings beat streak with a 10.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 314.88
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 26.5 versus sector average of 29.4
- Trading below the 200-day average of 314.88
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 26.5 versus sector average of 29.4
- Analyst targets imply +29.2% versus the current price
- Revenue growth of +190.0%
Key Metrics & Analysis
Financial Health
Revenue Growth190.00%
Profit Margin10.37%
P/E Ratio26.5
Debt/Equity34.57
P/B Ratio2.6
Op. Cash Flow$1.7B
Industry P/E29.4
Technical Analysis
TrendBearish
RSI34.1
Support$258.54
Resistance$294.14
MA 20$277.86
MA 50$285.48
MA 200$314.88
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66
Valuation
Fair Value$180.74
Target Price$339.50
Upside/Downside29.18%
GradeUndervalued
TypeBlend
Dividend Yield1.91%
Risk Assessment
Beta0.31
Volatility38.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.